obesity drug news today glp-1 The next phase of the race Obesity Drug Pipeline Expands with

Bowser, J

Regulating its production or signaling pathways provides a promising strategy for restoring immune metabolic balance and reducing intestinal inflammation

IGF-1 induces hypoxia-inducible factor 1-mediated GLUT3 expression through PI3K/Akt/mTOR dependent pathways in PC12 cells

It functions as a cofactor for lysyl oxidase (the enzyme responsible for collagen cross-linking and stabilization), ceruloplasmin (a copper transport protein with antioxidant activity), and superoxide dismutase (SOD, a primary antioxidant defense enzyme)

It may, however, be one biochemical contributor or aggravating factor in a susceptible patient